The biodrook team is proud to announce that our project has been recognized as one of Ukraine’s 25 most promising tech startups by Forbes. This achievement underscores the importance of our mission—to create fast, accessible, and innovative solutions for regenerative medicine.
biodrook has focused its efforts on producing 3D-printed bone implants that transform into the patient’s own bone tissue. Our solutions will be valuable to medical institutions treating patients with bone defects, particularly among military personnel. Thanks to mobile and stationary production platforms, implant manufacturing time has been reduced to 48 hours, allowing us to quickly meet needs even in the most remote parts of the country.
The company continues to grow rapidly, preparing to launch large-scale production in Ukraine and enter international markets. Our partners, such as Biopharma, The Mount Sinai Health System, DSM, and EVONIK, support us in introducing innovative technologies in Ukraine and integrating them into the medical sectors of the EU and the U.S.
Biodrook is grateful to Forbes for its high recognition and support of innovative solutions that help transform medicine today and in the future. We will continue working to make medical technologies accessible to everyone who needs them.
Stay tuned for our updates, because
